Massive french study aims to unlock secrets of heart infection

NCT ID NCT03272724

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is creating a large national database of infective endocarditis, a serious heart infection. Researchers will collect information from 5,000 patients across France to understand the disease's causes, risk factors, and how it is currently treated. The goal is to improve future care by analyzing real-world data, not by testing a new drug or procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this observatory could provide a clearer picture of infective endocarditis, helping doctors improve diagnosis and treatment strategies.

What could go wrong

This is an observational study, not a clinical trial testing a new treatment. It collects data only, so it won't directly change patient care. Results depend on the quality and completeness of data from participating centers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTIVE ENDOCARDITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocarditis infective endocarditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • CHRU

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

    Contact Email: •••••@•••••